W Advisors LLC Buys New Shares in CVS Health Co. (NYSE:CVS)

W Advisors LLC purchased a new stake in CVS Health Co. (NYSE:CVS) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 7,622 shares of the pharmacy operator’s stock, valued at approximately $450,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. USA Financial Formulas grew its holdings in CVS Health by 573.2% during the fourth quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock worth $30,000 after purchasing an additional 321 shares during the period. Ables Iannone Moore & Associates Inc. acquired a new stake in shares of CVS Health in the fourth quarter valued at approximately $32,000. First Community Trust NA boosted its stake in shares of CVS Health by 116.2% during the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after acquiring an additional 302 shares during the period. Creekmur Asset Management LLC bought a new stake in CVS Health in the 4th quarter valued at $34,000. Finally, Steph & Co. lifted its holdings in CVS Health by 192.0% during the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after purchasing an additional 288 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

Analysts Set New Price Targets

CVS has been the topic of several research reports. JPMorgan Chase & Co. decreased their price objective on shares of CVS Health from $101.00 to $86.00 and set an “overweight” rating on the stock in a report on Thursday, May 30th. Barclays lowered their price target on shares of CVS Health from $65.00 to $63.00 and set an “equal weight” rating on the stock in a report on Thursday, August 8th. Deutsche Bank Aktiengesellschaft reduced their price objective on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a report on Friday, August 9th. Royal Bank of Canada reissued an “outperform” rating and set a $68.00 price target on shares of CVS Health in a report on Wednesday. Finally, Baird R W raised CVS Health to a “hold” rating in a report on Thursday, May 30th. Eleven analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $72.48.

CVS Health Price Performance

Shares of NYSE:CVS opened at $57.75 on Friday. The firm has a 50 day moving average of $58.29 and a 200-day moving average of $63.78. CVS Health Co. has a 12 month low of $52.77 and a 12 month high of $83.25. The company has a current ratio of 0.86, a quick ratio of 0.66 and a debt-to-equity ratio of 0.83. The stock has a market capitalization of $72.50 billion, a PE ratio of 10.15, a PEG ratio of 0.80 and a beta of 0.53.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, beating the consensus estimate of $1.73 by $0.10. The business had revenue of $91.23 billion during the quarter, compared to the consensus estimate of $91.41 billion. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The company’s revenue was up 2.6% on a year-over-year basis. During the same period in the previous year, the business earned $2.21 earnings per share. On average, equities research analysts predict that CVS Health Co. will post 6.52 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, August 1st. Shareholders of record on Monday, July 22nd were given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.61%. The ex-dividend date of this dividend was Monday, July 22nd. CVS Health’s dividend payout ratio is presently 46.75%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.